Steriflex No.30 potassium chloride 0.2% (potassium 13.3mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

steriflex no.30 potassium chloride 0.2% (potassium 13.3mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags

potassium 13.3mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags (fresenius kabi ltd - potassium chloride; sodium chloride; glucose anhydrous - infusion - 2mg/1ml ; 1.8mg/1ml ; 40mg/1ml

POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE- potassium chloride, dextrose monohydrate and sodium chloride injection, solu Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

potassium chloride in dextrose and sodium chloride- potassium chloride, dextrose monohydrate and sodium chloride injection, solu

baxter healthcare corporation - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - potassium chloride 150 mg in 100 ml - potassium chloride in dextrose and sodium chloride injection is indicated as a source of water, electrolytes and calories. potassium chloride in dextrose and sodium chloride injection is contraindicated in patients with: risk summary appropriate administration of potassium chloride in dextrose sodium chloride injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. animal reproduction studies have not been conducted with potassium chloride in dextrose sodium chloride injection. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary sodium and potassium are present in human breast milk. there are no data on the effects

SODIUM CHLORIDE irrigant Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

sodium chloride irrigant

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium cation 0.9 g in 100 ml - 0.9% sodium chloride irrigation usp is indicated for all general irrigation, washing, rinsing and dilution purposes which permit use of a sterile, nonpyrogenic electrolyte solution. 0.9% sodium chloride irrigation usp is not for injection by usual parenteral routes. an electrolyte solution should not be used for irrigation during electrosurgical procedures.

Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 5% infusion 500ml bags

potassium 10mmol/500ml) / glucose 5% infusion 500ml bags (baxter healthcare ltd - glucose anhydrous; potassium chloride - infusion - 50mg/1ml ; 1.5mg/1ml

Potassium chloride 0.3% (potassium 40mmol/1litre) / Glucose 5% infusion 1litre Viaflo bags Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 5% infusion 1litre viaflo bags

potassium 40mmol/1litre) / glucose 5% infusion 1litre viaflo bags (baxter healthcare ltd - glucose anhydrous; potassium chloride - infusion - 50mg/1ml ; 3mg/1ml

SODIUM CHLORIDE injection, solution Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

sodium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. this product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. consult prescribing information for indications and usage  of drug additives to be administered in this manner. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.

VYTRATE SCOUR TREATMENT Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vytrate scour treatment

zoetis australia pty ltd - glycine; citric acid anhydrous; glucose anhydrous; potassium citrate; potassium phosphate monobasic; sodium chloride - oral powder, pre-mix - glycine amino acid-glycine active 6.18 g/sa; citric acid anhydrous acid-general active 0.48 g/sa; glucose anhydrous carbohydrate active 44.61 g/sa; potassium citrate mineral-potassium active 0.12 g/sa; potassium phosphate monobasic mineral-potassium active 4.08 g/sa; sodium chloride mineral-sodium-salt active 8.58 g/sa - alimentary system - calf | cat | dog | horse foal | lamb | pigs | beef calf | bitch | boar | bovine | calf - poddy | calf - preweaning | calf - suck - dehydration | scours | stress | selenium responsive scours